JP2004503525A5 - - Google Patents

Download PDF

Info

Publication number
JP2004503525A5
JP2004503525A5 JP2002510429A JP2002510429A JP2004503525A5 JP 2004503525 A5 JP2004503525 A5 JP 2004503525A5 JP 2002510429 A JP2002510429 A JP 2002510429A JP 2002510429 A JP2002510429 A JP 2002510429A JP 2004503525 A5 JP2004503525 A5 JP 2004503525A5
Authority
JP
Japan
Prior art keywords
chem
trans
chiral
cispentacin
pharm
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002510429A
Other languages
English (en)
Japanese (ja)
Other versions
JP3872427B2 (ja
JP2004503525A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2001/006541 external-priority patent/WO2001096285A1/en
Publication of JP2004503525A publication Critical patent/JP2004503525A/ja
Publication of JP2004503525A5 publication Critical patent/JP2004503525A5/ja
Application granted granted Critical
Publication of JP3872427B2 publication Critical patent/JP3872427B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002510429A 2000-06-14 2001-06-08 β−アミノ酸ニトリル誘導体 Expired - Fee Related JP3872427B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00112577 2000-06-14
PCT/EP2001/006541 WO2001096285A1 (en) 2000-06-14 2001-06-08 Beta-amino acid nitrile derivatives

Publications (3)

Publication Number Publication Date
JP2004503525A JP2004503525A (ja) 2004-02-05
JP2004503525A5 true JP2004503525A5 (https=) 2005-02-03
JP3872427B2 JP3872427B2 (ja) 2007-01-24

Family

ID=8168969

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002510429A Expired - Fee Related JP3872427B2 (ja) 2000-06-14 2001-06-08 β−アミノ酸ニトリル誘導体

Country Status (28)

Country Link
US (1) US6462076B2 (https=)
EP (1) EP1294679B1 (https=)
JP (1) JP3872427B2 (https=)
KR (1) KR20030029057A (https=)
CN (1) CN1324006C (https=)
AR (1) AR031594A1 (https=)
AT (1) ATE304997T1 (https=)
AU (2) AU6605601A (https=)
BR (1) BR0111733A (https=)
CA (1) CA2410303C (https=)
DE (1) DE60113533T2 (https=)
EC (1) ECSP024383A (https=)
ES (1) ES2248346T3 (https=)
HR (1) HRP20020963A2 (https=)
HU (1) HUP0300896A3 (https=)
IL (1) IL153166A0 (https=)
JO (1) JO2234B1 (https=)
MA (1) MA26913A1 (https=)
MX (1) MXPA02012253A (https=)
NO (1) NO20025823L (https=)
NZ (1) NZ522587A (https=)
PE (1) PE20020064A1 (https=)
PL (1) PL359811A1 (https=)
RU (1) RU2245871C2 (https=)
UY (1) UY26769A1 (https=)
WO (1) WO2001096285A1 (https=)
YU (1) YU90802A (https=)
ZA (1) ZA200209415B (https=)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9916575D0 (en) * 1999-07-15 1999-09-15 Cambridge Combinatorial Ltd Solid phase nitrile synthesis
EP1372655B1 (en) * 2001-03-02 2008-10-01 Merck Frosst Canada Ltd. Cathepsin cysteine protease inhibitors
BR0212451A (pt) * 2001-09-13 2004-10-19 Hoffmann La Roche Antagonistas de receptores de ccr-3 v
US6759428B2 (en) * 2001-12-04 2004-07-06 Roche Palo Alto Llc Indole nitriles
JP2005517640A (ja) * 2001-12-04 2005-06-16 エフ.ホフマン−ラ ロシュ アーゲー 置換2−アミノ−シクロアルカンカルボキサアミドならびにシステインプロテアーゼインヒビターとしてのその使用
DE60332856D1 (de) * 2002-10-23 2010-07-15 Bristol Myers Squibb Co Auf glycinnitril basierende hemmer der dipeptidylpeptidase iv
AU2004242865A1 (en) * 2003-06-02 2004-12-09 F. Hoffmann-La Roche Ag Benzamide nitrile derivatives
WO2005000793A1 (ja) * 2003-06-26 2005-01-06 Taisho Pharmaceutical Co., Ltd. 2位置換シクロアルキルカルボン酸誘導体
WO2005000800A1 (en) * 2003-06-30 2005-01-06 Merck Frosst Canada Ltd. Cathepsin cysteine protease inhibitors
EP1841730A4 (en) * 2005-01-19 2010-10-27 Merck Frosst Canada Ltd CATHEPSIN K INHIBITORS AND ATHEROSCLEROSIS
JP5122447B2 (ja) * 2005-07-06 2013-01-16 メルク カナダ インコーポレイテッド カテプシンシステインプロテアーゼ阻害剤
EP2719700A1 (en) 2008-01-09 2014-04-16 Amura Therapeutics Limited Tetrahydrofuro(3,2-b)pyrrol-3-one derivatives as inhibitors of cysteine proteinases
US7893099B2 (en) * 2009-06-11 2011-02-22 Hoffman-La Roche Inc. Cyclopentane derivatives
JP6021910B2 (ja) 2011-07-26 2016-11-09 サノフイ 3−ヘテロアロイルアミノ−プロピオン酸誘導体及び医薬としてのそれらの使用
CN103086923B (zh) * 2013-01-21 2014-04-23 吉林大学 肼腈类组织蛋白酶k抑制剂及其在治疗骨质疏松症方面的应用
WO2015054089A1 (en) * 2013-10-08 2015-04-16 Merck Sharp & Dohme Corp. Cathepsin cysteine protease inhibitors
NO2699580T3 (https=) 2014-01-24 2018-02-24
CN105837479B (zh) * 2016-04-05 2017-10-27 吉林大学 肼腈类组织蛋白酶k抑制剂及其在制备治疗骨关节炎药物中的应用
KR20250002710A (ko) 2018-03-01 2025-01-07 아스트라제네카 에이비이 (2s)-n-{(1s)-1-시아노-2-[4-(3-메틸-2-옥소-2,3-디하이드로-1,3-벤족사졸-5-일)페닐]에틸}-1,4-옥사제판-2-카복스아미드를포함하는 약학 조성물
AU2019306532A1 (en) 2018-07-17 2021-03-04 Insmed Incorporated Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides for treating Lupus Nephritis
CN113045491B (zh) * 2019-12-26 2024-09-06 罗欣药业(上海)有限公司 一种仑伐替尼及中间体的制备方法
CN115996923B (zh) 2020-08-26 2025-07-18 海思科医药集团股份有限公司 一种作为二肽基肽酶1抑制剂的腈衍生物及其用途
AU2021391452A1 (en) 2020-12-04 2023-06-29 Reistone Biopharma Company Limited Small molecule inhibitor of cathepsin c and medicinal use thereof
CN119156384B (zh) 2022-06-07 2025-12-09 瑞石生物医药有限公司 苯并[c]色满化合物的多晶型及其制备方法和用途
JP2025518345A (ja) 2022-06-07 2025-06-12 瑞石生物医薬有限公司 ベンゾ[c]クロマン化合物の薬学的に許容される塩、ならびに薬学的に許容される塩の多形及び使用
EP4646265A1 (en) 2023-01-06 2025-11-12 Insmed Incorporated Novel, reversible dpp1 inhibitors and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU177576B (en) 1975-06-02 1981-11-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing 2-amino-cyclohexane carboxylic acid,its amides and similar compounds
HU185876B (en) * 1980-02-29 1985-04-28 Egyt Gyogyszervegyeszeti Gyar Composition for controlling growth of plants and process for producing the active agent
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
IT1283467B1 (it) 1996-07-19 1998-04-21 Menarini Farma Ind Derivati di cicloalcani 1,2 sostituiti come inibitori della trombina, procedimento per la loro preparazione e loro impiego in formulazioni
EP1024134A4 (en) * 1997-10-09 2003-05-14 Ono Pharmaceutical Co DERIVATIVES OF AMINOBUTANIC ACID
TR200001189T2 (tr) 1997-11-05 2000-09-21 Novartis Ag. Dipeptid nitriller.

Similar Documents

Publication Publication Date Title
JP2004503525A5 (https=)
JP2001520998A5 (https=)
AU2002223640A1 (en) Fusion proteins as immunization treatments of alzheimer's disease
AU2003206413A1 (en) Substituted amino carboxamides for the treatment of alzheimer's disease
EE200400107A (et) Protsess kõrgpuhta perindopriili ning sünteesis kasulike vaheühendite valmistamiseks
JP2002513761A5 (https=)
CY1112047T1 (el) Διαδικασια για την παρασκευη γκαμπαπεντινης
JP2001520991A5 (https=)
JPH10139702A5 (https=)
JP2003171388A5 (https=)
TWM278428U (en) Air cushion for exercise
AU2003250392A1 (en) Benzoprostacyclin intermediates and methods for their preparation
TH18368S1 (th) "กะทะล้อถอดได้"
TH52753S (th) หัวไม้กอล์ฟ
TH76729S (th) เก้าอี้
TH25377S1 (th) เก้าอี้
TWD118854S1 (zh) 木質高爾夫球桿頭
TH77337S (th) เตาอบไมโครเวฟ
TH29575S1 (th) "เตาอบไมโครเวฟ"
TH29574S1 (th) เตาอบไมโครเวฟ
TH78243S (th) "เตาอบไมโครเวฟ"
TH98652S (th) ฝาจุกกาวน้ำ
TWD108710S1 (zh) 電視機(三十八)
TH79539S (th) เก้าอี้
TH25493S1 (th) เก้าอี้